(Download: Packaging Validation in PDF by Medistri)
Before a sterile medical device can be placed on the market, its packaging system must be validated under conditions representative of sterilization, storage, transport, and handling.
A packaging validation strategy defines how this evidence will be generated. At the Go-to-Market stage, this means identifying the configurations to be tested, the conditions to be simulated, and the methods required to demonstrate that the sterile barrier remains intact.
Defining the Validation Strategy
Packaging validation should reflect the final product and the conditions it will encounter throughout its intended lifecycle. The strategy may consider the packaging materials and configuration, product characteristics, sealing process, sterilization method, distribution conditions, and claimed shelf life.
These parameters define the conditions under which the packaging system must perform and provide the basis for selecting the appropriate validation activities.
Selecting Representative Configurations
Medical devices may be available in several sizes, weights, or packaging configurations. A validation strategy must therefore define which configurations will be included in testing.
Where representative or worst-case configurations are used, their selection should be justified based on the characteristics that may affect packaging performance. Product weight and dimensions, packaging geometry, material combinations, seal characteristics, and sensitivity to mechanical stresses can all influence this assessment.
Environmental and Distribution Conditions
Packaging systems are exposed to different stresses before reaching the point of use. Temperature and humidity variations, vibration, compression, impact, and handling can affect both the packaging and the sterile barrier.
Environmental conditioning is used to expose packaged products to defined climatic conditions. Transport simulation then reproduces mechanical stresses associated with the intended distribution cycle. The conditions applied should be selected according to the product, packaging configuration, and expected distribution environment.
Sterile Barrier Integrity
Following conditioning and transport simulation, the packaging system is tested to confirm that its required characteristics have been maintained. Depending on the packaging system, testing may include seal strength, package integrity, and methods used to identify channels, leaks, or other defects.
The results provide documented evidence of packaging performance after the stresses defined in the validation protocol.
Packaging and Shelf Life
The packaging system must also maintain its required performance throughout the claimed shelf life of the product. Aging studies can be incorporated into the validation strategy to evaluate packaging performance over time. Accelerated aging may be used to generate supporting data within shorter development timelines, while real-time aging continues under defined storage conditions.
Preparing for Market Entry
Packaging validation generates part of the technical evidence required to support a sterile medical device at market entry. For an efficient Go-to-Market pathway, packaging activities should be planned alongside sterilization validation and shelf-life studies. Aligning these activities early helps define testing requirements, establish appropriate configurations, and avoid additional validation work late in the development process.
The resulting documentation provides traceable evidence that the packaging system has been evaluated under defined conditions and is suitable for its intended use.
Packaging Validation at Medistri
Medistri supports packaging validation programs for medical devices and pharmaceuticals. Our teams work with manufacturers to define testing strategies according to the product, packaging system, sterilization process, and intended distribution conditions, generating the documentation required to support Go-to-Market activities.
To learn more about Medistri’s Packaging Validation Services, visit our website here or contact us at contact@medistri.com.
– The Medistri Team
#Medistri
Medistri is Europe's leading independent contract sterilization company, founded in 2006 and headquartered in the heart of Switzerland. We are a global player providing essential infrastructure that powers healthcare innovation worldwide.
We serve customers of all sizes, from startups, university projects, and research institutes to Fortune 500 corporations, across Medical Devices, Pharmaceutical Packaging, and Biotech.
Medistri supports products at every stage of the lifecycle: pre-clinical development, go-to-market, and full industrialization.
Our fully integrated, end-to-end in-house solution allows our customers to focus on what matters most: engineering, innovation, and development, while we manage the critical back-end processes.
Our synchronized departments work together to provide a complete stack of services:
- Contract Sterilization & Validation Services
- Contract Laboratory Services
- Contract Manufacturing Services
- Logistics Services
- Consulting Services
We help you accelerate time-to-market, reduce barriers to scale, and deliver safer, more sustainable healthcare solutions to patients around the world.
Medistri Solutions for Products in Go-to-Market Phase
In the go-to-market phase, precision and speed are critical to demonstrate regulatory readiness, secure market access, and launch with confidence.
Medistri acts as your trusted, fully integrated infrastructure partner, providing a comprehensive suite of in-house Solutions tailored to support validation, submission, and commercial readiness.
Our solutions include packaging validation, shelf-life studies, cleaning & reprocessing validation, sterilization validation, custom cycle development, laboratory method validation, support-to-submission services, post-validation training, EO-free supply chain validation, CE Mark pathway consulting, and MDR transition consulting.
By managing the entire validation and compliance process under one roof in our Swiss facility, Medistri eliminates multi-vendor complexity, accelerates regulatory timelines, ensures consistent data quality and traceability, and allows your team to focus on strategic market entry and commercial execution.
Enabling a smooth, compliant transition from development to successful product launch.